🚀 VC round data is live in beta, check it out!
Procter & Gamble Valuation Multiples
Discover revenue and EBITDA valuation multiples for Procter & Gamble and similar public comparables like AbbVie, L'Oreal, Novo Nordisk, Unilever and more.
Procter & Gamble Overview
About Procter & Gamble
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate annual global sales of more than $1 billion each, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.
Founded
1905
HQ
Employees
109.0K
Website
Sectors
Financials (LTM)
EV
$407B
Procter & Gamble Financials
Procter & Gamble reported last 12-month revenue of $86B and EBITDA of $24B.
In the same LTM period, Procter & Gamble generated $44B in gross profit, $24B in EBITDA, and $17B in net income.
Revenue (LTM)
Procter & Gamble P&L
In the most recent fiscal year, Procter & Gamble reported revenue of $84B and EBITDA of $24B.
Procter & Gamble expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $86B | XXX | $84B | XXX | XXX | XXX |
| Gross Profit | $44B | XXX | $43B | XXX | XXX | XXX |
| Gross Margin | 51% | XXX | 51% | XXX | XXX | XXX |
| EBITDA | $24B | XXX | $24B | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 28% | XXX | XXX | XXX |
| EBIT Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| Net Profit | $17B | XXX | $17B | XXX | XXX | XXX |
| Net Margin | 20% | XXX | 20% | XXX | XXX | XXX |
| Net Debt | — | — | $25B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Procter & Gamble Stock Performance
Procter & Gamble has current market cap of $380B, and enterprise value of $407B.
Market Cap Evolution
Procter & Gamble's stock price is $163.51.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $407B | $380B | 0.0% | XXX | XXX | XXX | $7.22 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialProcter & Gamble Valuation Multiples
Procter & Gamble trades at 4.7x EV/Revenue multiple, and 17.1x EV/EBITDA.
EV / Revenue (LTM)
Procter & Gamble Financial Valuation Multiples
As of March 7, 2026, Procter & Gamble has market cap of $380B and EV of $407B.
Equity research analysts estimate Procter & Gamble's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Procter & Gamble has a P/E ratio of 22.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $380B | XXX | $380B | XXX | XXX | XXX |
| EV (current) | $407B | XXX | $407B | XXX | XXX | XXX |
| EV/Revenue | 4.7x | XXX | 4.8x | XXX | XXX | XXX |
| EV/EBITDA | 17.1x | XXX | 17.0x | XXX | XXX | XXX |
| EV/EBIT | 19.6x | XXX | 19.9x | XXX | XXX | XXX |
| EV/Gross Profit | 9.3x | XXX | 9.4x | XXX | XXX | XXX |
| P/E | 22.5x | XXX | 22.7x | XXX | XXX | XXX |
| EV/FCF | 26.9x | XXX | 28.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Procter & Gamble Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Procter & Gamble Margins & Growth Rates
Procter & Gamble's revenue in the last 12 month grew by 3%.
Procter & Gamble's revenue per employee in the last FY averaged $0.8M.
Procter & Gamble's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Procter & Gamble's rule of X is 35% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Procter & Gamble Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 28% | XXX | 28% | XXX | XXX | XXX |
| EBITDA Growth | 4% | XXX | 1% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 31% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 35% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.8M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 11% | XXX | — | XXX | XXX | XXX |
| R&D Expenses to Revenue | 2% | XXX | — | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 27% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Procter & Gamble Public Comps
See public comps and valuation multiples for other Health & Beauty and Home Care comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| AbbVie | XXX | XXX | XXX | XXX | XXX | XXX |
| L'Oreal | XXX | XXX | XXX | XXX | XXX | XXX |
| Novo Nordisk | XXX | XXX | XXX | XXX | XXX | XXX |
| Unilever | XXX | XXX | XXX | XXX | XXX | XXX |
| EssilorLuxottica | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Procter & Gamble M&A Activity
Procter & Gamble acquired XXX companies to date.
Last acquisition by Procter & Gamble was on XXXXXXXX, XXXXX. Procter & Gamble acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Procter & Gamble
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialProcter & Gamble Investment Activity
Procter & Gamble invested in XXX companies to date.
Procter & Gamble made its latest investment on XXXXXXXX, XXXXX. Procter & Gamble invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Procter & Gamble
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Procter & Gamble
| When was Procter & Gamble founded? | Procter & Gamble was founded in 1905. |
| Where is Procter & Gamble headquartered? | Procter & Gamble is headquartered in United States. |
| How many employees does Procter & Gamble have? | As of today, Procter & Gamble has over 109K employees. |
| Who is the CEO of Procter & Gamble? | Procter & Gamble's CEO is Jon R. Moeller. |
| Is Procter & Gamble publicly listed? | Yes, Procter & Gamble is a public company listed on NYSE. |
| What is the stock symbol of Procter & Gamble? | Procter & Gamble trades under PG ticker. |
| When did Procter & Gamble go public? | Procter & Gamble went public in 1950. |
| Who are competitors of Procter & Gamble? | Procter & Gamble main competitors are AbbVie, L'Oreal, Novo Nordisk, Unilever. |
| What is the current market cap of Procter & Gamble? | Procter & Gamble's current market cap is $380B. |
| What is the current revenue of Procter & Gamble? | Procter & Gamble's last 12 months revenue is $86B. |
| What is the current revenue growth of Procter & Gamble? | Procter & Gamble revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Procter & Gamble? | Current revenue multiple of Procter & Gamble is 4.7x. |
| Is Procter & Gamble profitable? | Yes, Procter & Gamble is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Procter & Gamble? | Procter & Gamble's last 12 months EBITDA is $24B. |
| What is Procter & Gamble's EBITDA margin? | Procter & Gamble's last 12 months EBITDA margin is 28%. |
| What is the current EV/EBITDA multiple of Procter & Gamble? | Current EBITDA multiple of Procter & Gamble is 17.1x. |
| What is the current FCF of Procter & Gamble? | Procter & Gamble's last 12 months FCF is $15B. |
| What is Procter & Gamble's FCF margin? | Procter & Gamble's last 12 months FCF margin is 18%. |
| What is the current EV/FCF multiple of Procter & Gamble? | Current FCF multiple of Procter & Gamble is 26.9x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.